image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
Filing Date
May 04, 2022
Document Date
May 02, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Filer
Huang Jane